0001708138-20-000101.txt : 20200827 0001708138-20-000101.hdr.sgml : 20200827 20200827162132 ACCESSION NUMBER: 0001708138-20-000101 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200825 FILED AS OF DATE: 20200827 DATE AS OF CHANGE: 20200827 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Van Plew Daniel P CENTRAL INDEX KEY: 0001411984 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 201143134 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-08-25 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001411984 Van Plew Daniel P 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP & General Mgr Industrial O Common Stock 2020-08-25 4 S 0 10256 609.71 D 36854 D Common Stock 2020-08-25 4 S 0 7981 610.41 D 28873 D Common Stock 2020-08-25 4 S 0 1980 611.4 D 26893 D Common Stock 2020-08-25 4 S 0 4044 612.49 D 22849 D Common Stock 2020-08-25 4 S 0 1560 613.62 D 21289 D Common Stock 2020-08-25 4 S 0 1288 614.24 D 20001 D Common Stock 1028 I By 401(k) Plan Represents volume-weighted average price of sales of 10,256 shares of Company stock on August 25, 2020 at prices ranging from $609.18 to $609.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price. Represents volume-weighted average price of sales of 7,981 shares of Company stock on August 25, 2020 at prices ranging from $610.01 to $610.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price. Represents volume-weighted average price of sales of 1,980 shares of Company stock on August 25, 2020 at prices ranging from $611.00 to $611.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price. Represents volume-weighted average price of sales of 4,044 shares of Company stock on August 25, 2020 at prices ranging from $612.00 to $612.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price. Represents volume-weighted average price of sales of 1,560 shares of Company stock on August 25, 2020 at prices ranging from $613.08 to $613.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price. Represents volume-weighted average price of sales of 1,288 shares of Company stock on August 25, 2020 at prices ranging from $614.00 to $614.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 25, 2020 at each separate price. /s/**Daniel P. Van Plew 2020-08-26